AI is revolutionizing biology by treating DNA as a programmable language, enabling the creation of entirely new genetic sequences. A model called Evo, trained on 80,000 genomes, has generated a CRISPR-like gene-editing tool—marking one of the first times AI has designed a potentially functional biological system without human templates. This shift from reading to writing DNA opens transformative possibilities: personalized gene therapies, microbes tailored for life on Mars, and even de-extinction efforts. However, with this power comes risk—such technology could be misused to design harmful pathogens. The key lies in balancing rapid innovation with strong biosecurity frameworks. By building life, scientists gain deeper insight into how it works, pushing the boundaries of medicine and synthetic biology while urging caution in navigating the ethical landscape.